Alcohol dependence
Rare disease
No
- Definition
- Physical and psychological dependence on alcohol.
- Genetic basis
- Yes
- Non-human condition
- No
- Rare disease
- No
- Listing at source
- Listed
- Condition name
- Alcohol dependence
- alcohol dependence
- alcohol dependence
- alcoholism
- Severity
- Moderate
- MONDO ID
- MONDO:0007079
- Parent condition
- MONDO:0005303
Related records
Broader conditions (8)
- Alcohol-related disorders
- Disease
- Disease by developmental or physiological process
- Drug dependence
- Human disease
- Psychiatric disorder
- Substance dependence
- Substance-related disorder
Trials (1,655)
- "ALCO-VR": Virtual Reality Cue Exposure Therapy for the Treatment of Alcohol Use Disorder
- "Juego de LLaves": Study Protocol of a Universal School-based Drug Use Prevention Program (PSIDUP)
- [C-11]NOP-1A and Alcohol Use Disorder
- [C-11]PiB PET Imaging in Alcohol Use Disorders
- 10 Days of Theta Burst Stimulation as a Tool to Treat Cocaine Dependence
- 12-step Facilitation for the Dually Diagnosed
- 90-Day Online Substance Use Program
- A Behavioral Activation Intervention Administered in a College Freshman Orientation Course
- A Clinical Trial on the Efficacy of tDCS) in Reducing Alcohol Consumption in Non-abstinent Patients (REDSTIM)
- A Clinical Trial to Assess Pharmacokinetic Profiles, Safety and Tolerability of IVL3004 and IVL4002 in Healthy Male Subjects.
- A Combined Neurofeedback-TMS Intervention for Alcohol Use Disorder
- A Community-Based Strategy for Preventing Underage Drinking
- A Comparison of Adolescent Group Therapy and Transitional Family Therapy for Adolescent Alcohol and Drug Abusers
- A Controlled Trial of Extended Brief Interventions in Alcohol Dependent Patients
- A Controlled Trial of Topiramate Treatment for Alcohol Dependence in Veterans With PTSD
- A Critical Illness Recovery Navigator for Alcohol
- A Dialectical Behavioral Therapy Digital Health Solution for Outpatients Seeking Support for Substance Use
- A Digital Pill System to Measure and Support Acamprosate Adherence in Individuals With Alcohol Associated Liver Disease
- A Dose-Escalation Study to Determine the Maximum Tolerated Dose of Arbaclofen Placarbil in Subjects With Alcohol Use Disorder
- A Double-Blind Trial of Psilocybin-Assisted Treatment of Alcohol Dependence
Approved drugs (8)
- Acamprosate
- Acamprosate calcium
- Chlordiazepoxide
- Disulfiram
- Doxepin hydrochloride
- Nalmefene
- Nalmefene hydrochloride dihydrate
- Naltrexone
Drugs in development (113)
- Acetylcarnitine Phase 1
- Acetylcysteine Phase 2
- Alcohol Phase 3
- Amitifadine Phase 2
- Apomorphine Phase 2
- Apremilast Phase 2
- Aprepitant Phase 2
- Arbaclofen placarbil Phase 2
- Aripiprazole Phase 3
- Aticaprant Phase 2
- Atomoxetine Phase 2
- Baclofen Phase 3
- Bavisant Phase 2
- Brexanolone Phase 1
- Brexpiprazole Phase 2
- Bupropion hydrochloride Phase 2
- Caffeine Phase 1
- Calcium carbimide Phase 2
- Calcium carbonate Phase 3
- Cannabidiol Phase 2
Other linked drugs (9)
- Amperozide
- Chloral hydrate
- Diazepam
- Melperone
- Moxonidine
- Relacorilant
- Sulfasalazine
- Thiopental
- Tiapride